Neofect Co.Ltd (290660) - Net Assets
Based on the latest financial reports, Neofect Co.Ltd (290660) has net assets worth ₩54.30 Billion KRW (≈ $36.80 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩78.48 Billion ≈ $53.19 Million USD) and total liabilities (₩24.18 Billion ≈ $16.39 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Neofect Co.Ltd (290660) total assets for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩54.30 Billion |
| % of Total Assets | 69.19% |
| Annual Growth Rate | N/A |
| 5-Year Change | 330.33% |
| 10-Year Change | N/A |
| Growth Volatility | 77.74 |
Neofect Co.Ltd - Net Assets Trend (2016–2025)
This chart illustrates how Neofect Co.Ltd's net assets have evolved over time, based on quarterly financial data. Check Neofect Co.Ltd (290660) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Neofect Co.Ltd (2016–2025)
The table below shows the annual net assets of Neofect Co.Ltd from 2016 to 2025. For live valuation and market cap data, see market value of Neofect Co.Ltd.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩53.18 Billion ≈ $36.04 Million |
+36.71% |
| 2024-12-31 | ₩38.90 Billion ≈ $26.36 Million |
+34.45% |
| 2023-12-31 | ₩28.93 Billion ≈ $19.61 Million |
+202.19% |
| 2022-12-31 | ₩9.57 Billion ≈ $6.49 Million |
-22.53% |
| 2021-12-31 | ₩12.36 Billion ≈ $8.37 Million |
-18.92% |
| 2020-12-31 | ₩15.24 Billion ≈ $10.33 Million |
+22.80% |
| 2019-12-31 | ₩12.41 Billion ≈ $8.41 Million |
-56.07% |
| 2018-12-31 | ₩28.25 Billion ≈ $19.15 Million |
+264.38% |
| 2017-12-31 | ₩-17.19 Billion ≈ $-11.65 Million |
-21.36% |
| 2016-12-31 | ₩-14.16 Billion ≈ $-9.60 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Neofect Co.Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 5590321551000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₩124.52 Billion | 233.50% |
| Total Equity | ₩53.33 Billion | 100.00% |
Neofect Co.Ltd Competitors by Market Cap
The table below lists competitors of Neofect Co.Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Arn Media Ltd
AU:A1N
|
$56.48 Million |
|
Lucas GC Limited Ordinary Shares
NASDAQ:LGCL
|
$56.48 Million |
|
LEIFRAS Co., Ltd. American Depositary Shares
NASDAQ:LFS
|
$56.51 Million |
|
SECURE INC.
F:Q58
|
$56.52 Million |
|
Big Sunshine Co Ltd
TW:1475
|
$56.47 Million |
|
Chi Sheng Chemical
TWO:4111
|
$56.46 Million |
|
Datalex
IR:DLE
|
$56.45 Million |
|
Luks Kadife Ticaret ve Sanayi AS
IS:LUKSK
|
$56.41 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Neofect Co.Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 38,897,367,040 to 53,329,796,080, a change of 14,432,429,040 (37.1%).
- Net loss of 12,297,443,130 reduced equity.
- New share issuances of 11,499,999,380 increased equity.
- Other factors increased equity by 15,229,872,790.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-12.30 Billion | -23.06% |
| Share Issuances | ₩11.50 Billion | +21.56% |
| Other Changes | ₩15.23 Billion | +28.56% |
| Total Change | ₩- | 37.10% |
Book Value vs Market Value Analysis
This analysis compares Neofect Co.Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.56x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩-3017.28 | ₩1651.00 | x |
| 2017-12-31 | ₩-3539.71 | ₩1651.00 | x |
| 2018-12-31 | ₩2087.72 | ₩1651.00 | x |
| 2019-12-31 | ₩908.92 | ₩1651.00 | x |
| 2020-12-31 | ₩806.12 | ₩1651.00 | x |
| 2021-12-31 | ₩653.61 | ₩1651.00 | x |
| 2022-12-31 | ₩337.03 | ₩1651.00 | x |
| 2023-12-31 | ₩748.57 | ₩1651.00 | x |
| 2024-12-31 | ₩923.28 | ₩1651.00 | x |
| 2025-12-31 | ₩1056.48 | ₩1651.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Neofect Co.Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -23.06%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -76.61%
- • Asset Turnover: 0.21x
- • Equity Multiplier: 1.46x
- Recent ROE (-23.06%) is above the historical average (-49.21%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | -298.99% | 0.25x | 0.00x | ₩-4.50 Billion |
| 2017 | 0.00% | -98.54% | 0.44x | 0.00x | ₩-2.67 Billion |
| 2018 | -34.10% | -170.43% | 0.16x | 1.27x | ₩-12.46 Billion |
| 2019 | -127.66% | -128.70% | 0.26x | 3.79x | ₩-17.09 Billion |
| 2020 | -98.47% | -80.58% | 0.32x | 3.80x | ₩-16.53 Billion |
| 2021 | -40.82% | -21.78% | 0.44x | 4.25x | ₩-6.28 Billion |
| 2022 | -148.37% | -36.72% | 0.52x | 7.77x | ₩-10.27 Billion |
| 2023 | -17.15% | -18.65% | 0.37x | 2.48x | ₩-7.86 Billion |
| 2024 | -2.45% | -4.51% | 0.29x | 1.86x | ₩-4.84 Billion |
| 2025 | -23.06% | -76.61% | 0.21x | 1.46x | ₩-17.63 Billion |
Industry Comparison
This section compares Neofect Co.Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $120,744,551,957
- Average return on equity (ROE) among peers: 5.65%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Neofect Co.Ltd (290660) | ₩54.30 Billion | 0.00% | 0.45x | $56.48 Million |
| Shinhung (004080) | $113.89 Billion | 8.10% | 0.23x | $89.01 Million |
| HansBiomed Corporation (042520) | $39.39 Billion | 8.88% | 0.13x | $164.76 Million |
| JVM Co. Ltd (054950) | $123.61 Billion | 4.69% | 0.46x | $183.43 Million |
| U&I Corporation (056090) | $62.85 Billion | -1.29% | 0.23x | $65.92 Million |
| Huvitz Co. Ltd (065510) | $68.86 Billion | 9.49% | 0.66x | $51.23 Million |
| Vieworks Co. Ltd (100120) | $215.64 Billion | 6.82% | 0.36x | $147.13 Million |
| Corentec Co Ltd (104540) | $86.12 Billion | 4.71% | 1.17x | $33.36 Million |
| Hironic Co. Ltd (149980) | $58.67 Billion | 5.00% | 0.15x | $50.01 Million |
| Humasis Co. Ltd (205470) | $287.33 Billion | -19.29% | 0.21x | $164.10 Million |
| NH SPAC 2 (206640) | $151.09 Billion | 29.36% | 0.27x | $163.47 Million |
About Neofect Co.Ltd
Dynamic solution Co.,Ltd. researches, develops, manufactures, and sells rehabilitation medical devices and contents for stroke and spinal cord injuries. The company offers Neofect Smart Glove, a high-tech rehab device that measures movements of the forearm, wrist, and digits with accelerometer and bending sensors; Neofect Smart Kids for hand rehabilitation in children; Neofect Smart Board, a high… Read more